Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
CACNA1F - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
PreventionGenetics United States | 285 | 137 |
|
Invitae Congenital Stationary Night Blindness Panel Invitae United States | 36 | 22 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Invitae Inherited Retinal Disorders Panel Invitae United States | 486 | 293 |
|
Molecular Vision Laboratory United States | 342 | 268 |
|
Congenital Stationary Night Blindness Panel PreventionGenetics United States | 18 | 17 |
|
PreventionGenetics United States | 91 | 82 |
|
Cone-Rod Dystrophy (CORDX3) via the CACNA1F Gene PreventionGenetics United States | 3 | 1 |
|
Amsterdam UMC Genome Diagnostics Amsterdam University Medical Center, Location AMC Netherlands | 3 | 1 |
|
Baylor Genetics United States | 842 | 637 |
|
Congenital stationary night blindness panel. 17-gene NGS panel. Genologica Medica Spain | 25 | 17 |
|
Rod and cone dystrophy panel. 42-gene NGS panel. Genologica Medica Spain | 65 | 41 |
|
Retinal dystrophy panel. 260 gene NGS panel. Genologica Medica Spain | 420 | 257 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 3 | 1 |
|
Night blindness, congenital stationary: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 14 | 13 |
|
Congenital Stationary Night Blindness NGS Panel Fulgent Genetics United States | 27 | 17 |
|
Retinopathy and Optic Atrophy NGS Panel Fulgent Genetics United States | 563 | 241 |
|
Congenital Stationary Night Blindness , Panel Massive Sequencing (NGS) 13 Genes Reference Laboratory Genetics Spain | 14 | 13 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.